Tájékoztatjuk, hogy a Prima Medica EgészségHálózat 2025. január 25-én 09:00-15:20-ig a BKIK-ban (1016 Budapest, Krisztina krt. 99.) szakmai napot tart, amely „A diabetes mellitus korszerű terápiája” címen kerül megrendezésre.

A szakmai nap részletes programja megtekinthető ide kattintva

A szakmai napot a Szegedi Tudományegyetem akkreditálta. Orvosoknak 7 kreditpontot igazolhatunk a részvételért. A rendezvény térítésmentes.Jelentkezéseket a molnar.zsuzsanna@primamedica.hu címre várjuk.

ISUOG World Congress gives you the latest scientific research, practical workshops and an opportunity to meet and network with 3000 delegates from over 140 countries.

Our enhanced virtual platform will provide more opportunities to interact with your favourite speakers, engage with the content and network with the people you want to meet. 

Important dates:

• 15 October: Congress opens
• 17 October: Congress live-days ends
• 17 November (23:59 GMT): Access to Congress platform closes. On-demand content for Congress attendees will move to the ISUOG education pages here. Please note that ISUOG members who did not attend the 2021 Congress will only be able to access the recordings 12 months after the Congress. 

More information and registration on the website: https://www.isuog.org/events/world-congress-2021.html

LUPUS & CORA 2021 is going virtual

Considering the continued uncertainty, we are facing around the COVID-19 pandemic, and its impact on travel restrictions and physical distancing requirements, the LUPUS & CORA 2021 Organizing Committees have decided to transform this year’s congress in a fully virtual experience.

LUPUS & CORA 2021 will take place online on the same dates: 6-9 October 2021.

Early Registration Deadline: 1 September 2021

Gateway to the Future

The 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) together will 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA) will showcase the very best clinical, biological, and translational advances in the field of SLE and autoimmunity. At the joint congress we will highlight advances and insights from recent Systemic Lupus Erythematosus (SLE) research into the causes and outcomes of SLE, explore the promise of implementing a personalized approach to diagnosis, prognosis, and treatment, and provide a forum to hear exciting and innovative research from a new generation of investigators. The Congress will include an exceptional program focusing on the nexus between laboratory science and clinical translation, include multidisciplinary sessions on topics from B cells to nephritis, and offer a unique opportunity for the presentation of original data.

Learn more at https://lupus2021.kenes.com/

We look forward to seeing you online!